Amit Tevar, MD, discusses the kidney transplantation process and explains which high-risk cadaveric kidneys benefit different patients.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Recognize which HIV+ end-stage renal disease (ESRD) patients are eligible for HIV+ cadaveric transplant through the HOPE U01 trial and increase patient outcomes
- Identify ESRD,
nonreactive hepatitis C (HCV-) listed kidney transplant patients that would benefit from receipt of HCV+ cadaveric organ through an International Review Board-approved trial
- Explain which high-risk cadaveric kidney offers can be screened through the UNOS UNet system prior to organ offer
Disclosures
Dr. Tevar has financial interests with the following entity or entities producing health care goods or services as indicated below:
Dr. Tevar is on the Advisory Board, CSL Behring
All presenters' disclosures of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers, and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation Statement
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.075) continuing education units (CEUs) which are equivalent to 0.75 contact hours.
For your credit transcript, please access our website four weeks postcompletion at http://ccehs.upmc.com and follow the link to the Credit Transcript page.
Release Date: 9/17/2019 | Last Modified On: 9/17/2019 | Expires: 9/17/2020
